Appendix cancer
MONDO:0001235A malignant neoplasm involving the vermiform appendix
Also known as: cancer of vermiform appendix, malignant appendix neoplasm, malignant appendix tumor, malignant appendix tumour, malignant neoplasm of appendix, malignant neoplasm of appendix vermiformis, malignant neoplasm of the appendix, malignant neoplasm of vermiform appendix
2921 clinical trials for this condition and its sub-types, 19 tagged with Appendix cancer itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Appendix cancer
-
Appendix carcinoma 11 trials · 42 incl. sub-types
3 sub-types
- Appendix adenocarcinoma 12 trials · 31 incl. sub-types Sub-types →
- Goblet cell carcinoma 2 trials
- Carcinoma in situ of appendix 0 trials
-
Appendix lymphoma 0 trials
Most studied deeper sub-types
-
Chemotherapy as a fine mist: could PIPAC reduce side effects for abdominal cancer patients?
Disease control Recruiting nowThis early-phase trial tests a technique called PIPAC, which turns liquid chemotherapy into a fine mist sprayed directly into the abdomen during a minimally invasive surgery. It aims to see if this approach is safe and causes fewer side effects than standard chemotherapy. The stu…
Phase 1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Zapping spreading tumors could extend life on current cancer drugs
Disease control Recruiting nowThis study tests whether adding a targeted, tumor-destroying treatment (like focused radiation or heat ablation) can help people with certain gastrointestinal cancers—such as colorectal, small bowel, or pancreatic cancer—continue their current systemic therapy longer when only a …
Sponsor: University of California, Davis • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Tailored chemo doses could boost GI cancer treatment
Disease control Recruiting nowThis study tests a new way to give chemotherapy for gastrointestinal cancers like colorectal and stomach cancer. Doctors will adjust the dose of one chemo drug (5-FU) based on how well each patient tolerates it, aiming to give higher doses to those who can handle it without sever…
Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New PET scan technique could sharpen cancer detection in the gut
Diagnosis Recruiting nowThis study is testing a new type of PET scan that uses special probes to highlight digestive system cancers, such as stomach, liver, colon, and pancreatic cancers. Researchers will enroll 400 adults to see how well this imaging method finds tumors and tracks their response to tre…
Sponsor: RenJi Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 08:07 UTC
-
Glowing dye could help surgeons spot hidden cancers during surgery
Diagnosis Recruiting nowThis study tests whether a dye called pafolacianine (CYTALUX™) can make cancer cells glow under near-infrared light during surgery. Fifteen adults with gastric, esophageal, or appendiceal cancer will receive the dye before standard surgery. Surgeons will use a special camera to l…
Phase 4 • Sponsor: Cedars-Sinai Medical Center • Aim: Diagnosis
Last updated Jun 26, 2026 17:19 UTC
-
Virtual reality goggles could be new tool against cancer pain
Symptom relief Recruiting nowThis study tests whether using virtual reality (VR) can reduce severe belly pain and improve quality of life in people with digestive tract cancers. 360 participants will be split into three groups: one using a skills-based VR program, one using distracting VR videos, and a contr…
Sponsor: Cedars-Sinai Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 09:07 UTC
-
New study aims to close gaps in cancer care for black patients
Knowledge-focused Recruiting nowThis study is for Black adults newly diagnosed with gastrointestinal cancer. It focuses on ensuring patients receive proper biomarker testing and evidence-based care, helping them find and join clinical trials if they choose, and providing easy-to-understand information about the…
Sponsor: Case Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Scientists try to personalize heated chemo for stomach cancers
Knowledge-focused Recruiting nowThis study looks at a treatment called HIPEC, where heated chemotherapy is washed inside the abdomen after surgery to remove tumors. Researchers want to see if lab-grown tumor models can predict how well the chemotherapy works. Sixty adults with cancers that have spread to the ab…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Aug 27, 2026 00:00 UTC
-
Patient stories could unlock new treatments for rare appendix cancer
Knowledge-focused Recruiting nowThis study is building a global patient registry to collect real-world information from people diagnosed with appendix cancer or pseudomyxoma peritonei (PMP), a rare condition where tumors spread in the abdomen. Participants and caregivers share details about their symptoms, trea…
Sponsor: Appendix Cancer Pseudomyxoma Peritonei Research Foundation • Aim: Knowledge-focused
Last updated Aug 19, 2026 00:00 UTC
-
Personalized chemo test aims to improve treatment for advanced abdominal cancers
Knowledge-focused Recruiting nowThis study tests a new method called mass-based response testing (MRT) to help doctors choose the best chemotherapy drugs for patients with advanced appendix or colorectal cancer that has spread to the abdomen. The MRT device analyzes live tumor cells to see which drugs work best…
Sponsor: Yale University • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC
-
Scientists dig into DNA of rare gut cancer to improve prognosis
Knowledge-focused Recruiting nowThis study looks at stored tumor samples from 400 people with appendiceal cancer. Researchers will analyze DNA and RNA modifications to find patterns linked to how the cancer behaves. The goal is to create a molecular score that could one day help doctors predict outcomes more ac…
Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC